172 related articles for article (PubMed ID: 14616341)
1. Viral warts in organ transplant recipients: new aspects in therapy.
Schmook T; Nindl I; Ulrich C; Meyer T; Sterry W; Stockfleth E
Br J Dermatol; 2003 Nov; 149 Suppl 66():20-4. PubMed ID: 14616341
[TBL] [Abstract][Full Text] [Related]
2. Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients.
Trakatelli M; Katsanos G; Ulrich C; Kalabalikis D; Sotiriadis D; Stockfleth E
Int J Immunopathol Pharmacol; 2010; 23(2):387-96. PubMed ID: 20646334
[TBL] [Abstract][Full Text] [Related]
3. 5% topical imiquimod tolerance in transplant recipients.
Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
Ahn CS; Huang WW
Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
Grussendorf-Conen EI; Jacobs S
Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
[TBL] [Abstract][Full Text] [Related]
6. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Hengge UR; Cusini M
Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod treatment of human papillomavirus in a patient with human immunodeficiency virus.
Gilbert J; Drehs MM; Weinberg JM
Acta Derm Venereol; 2001; 81(4):301-2. PubMed ID: 11720183
[No Abstract] [Full Text] [Related]
8. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
10. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.
Stockfleth E; Ulrich C; Meyer T; Christophers E
Recent Results Cancer Res; 2002; 160():251-8. PubMed ID: 12079221
[TBL] [Abstract][Full Text] [Related]
11. [Warts and epidermoid carcinoma after renal transplantation].
Euvrard S; Chardonnet Y; Hermier C; Viac J; Thivolet J
Ann Dermatol Venereol; 1989; 116(3):201-11. PubMed ID: 2545155
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
[TBL] [Abstract][Full Text] [Related]
14. [Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management].
Krüger-Corcoran D; Stockfleth E; Jürgensen JS; Maltusch A; Nindl I; Sterry W; Lange-Asschenfeldt B; Ulrich C
Hautarzt; 2010 Mar; 61(3):220-9. PubMed ID: 20165825
[TBL] [Abstract][Full Text] [Related]
15. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
17. Use of topical immunomodulators in organ transplant recipients.
Kovach BT; Stasko T
Dermatol Ther; 2005; 18(1):19-27. PubMed ID: 15842609
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
19. [Imiquimod in the treatment of recalcitrant warts: a new therapy option?].
Hesterberg U; Böhlen LM; Brand CU
Praxis (Bern 1994); 2003 Mar; 92(12):535-9. PubMed ID: 12693144
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.
Juschka U; Hartmann M
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():48-50. PubMed ID: 14616816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
